We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-2.6%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$610B
AUM Growth
-$181B
Cap. Flow
-$168B
Cap. Flow %
-27.5%
Top 10 Hldgs %
30.63%
Holding
3,114
New
154
Increased
1,364
Reduced
1,248
Closed
171

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$1.76B
2
LLY icon
Eli Lilly
LLY
+$1.4B
3
BAC icon
Bank of America
BAC
+$1.3B
4
TSLA icon
Tesla
TSLA
+$1.19B
5
WFC icon
Wells Fargo
WFC
+$784M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$6.47B
2
AMZN icon
Amazon
AMZN
+$3.71B
3
YUM icon
Yum! Brands
YUM
+$2.84B
4
CRM icon
Salesforce
CRM
+$2.77B
5
FTV icon
Fortive
FTV
+$2.41B

Sector Composition

Rank Sector Weight
1 Technology 26.06%
2 Healthcare 18.72%
3 Consumer Discretionary 14.62%
4 Financials 10.36%
5 Communication Services 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRBP icon
2926
Corbus Pharmaceuticals
CRBP
$189M
$10K ﹤0.01%
1,877
MTEM
2927
DELISTED
Molecular Templates, Inc.
MTEM
$8K ﹤0.01%
667
-1,238
-65% -$15.6K
DOMA
2928
DELISTED
Doma Holdings, Inc.
DOMA
$8K ﹤0.01%
696
+173
+33% +$3.11K
STAB
2929
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$8K ﹤0.01%
61,200
BOAC.WS
2930
DELISTED
Bluescape Opportunities Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
BOAC.WS
$7K ﹤0.01%
46,500
AUD
2931
DELISTED
Audacy, Inc.
AUD
$5K ﹤0.01%
12,106
+1,193
+11% +$721
GVCIW
2932
DELISTED
Green Visor Financial Technology Acquisition Corp. I Warrants
GVCIW
$4K ﹤0.01%
37,925
VTGN icon
2933
VistaGen Therapeutics
VTGN
$11.6M
$3K ﹤0.01%
598
-2,380
-80% -$23.6K
NBIS
2934
Nebius Group N.V.
NBIS
$70.5B
$3K ﹤0.01%
5,603,665
+69,578
+1% +$37
ONYXW
2935
DELISTED
Onyx Acquisition Co. I Warrant
ONYXW
$3K ﹤0.01%
37,750
PRPC.WS
2936
DELISTED
CC Neuberger Principal Holdings III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PRPC.WS
$3K ﹤0.01%
12,125
MLAIW
2937
DELISTED
McLaren Technology Acquisition Corp. Warrant
MLAIW
$3K ﹤0.01%
37,750
AFACW
2938
DELISTED
Arena Fortify Acquisition Corp. Warrant
AFACW
$3K ﹤0.01%
37,500
VELOW
2939
DELISTED
Velocity Acquisition Corp. Warrant
VELOW
$2K ﹤0.01%
11,329
HAACW
2940
DELISTED
Health Assurance Acquisition Corp. Warrants
HAACW
$2K ﹤0.01%
35,000
EUCRW
2941
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$1K ﹤0.01%
22,697
ADVWW
2942
DELISTED
Advantage Solutions Warrant
ADVWW
-579,414
Closed -$133K
AEM icon
2943
Agnico Eagle Mines
AEM
$93.8B
-19,749
Closed -$902K
ALC icon
2944
Alcon
ALC
$35.6B
-21,598,794
Closed -$1.51B
ANF icon
2945
CALL
Abercrombie & Fitch
ANF
$4.99B
-378,000
Closed -$12.9M
APEI icon
2946
American Public Education
APEI
$826M
-1,843,974
Closed -$29.8M
ARIS
2947
DELISTED
Aris Water Solutions
ARIS
-2,160,423
Closed -$36M
BCE icon
2948
BCE
BCE
$21.6B
-5,200
Closed -$255K
BLBD icon
2949
Blue Bird Corp
BLBD
$2.04B
-1,868,512
Closed -$17.2M
BLFY
2950
DELISTED
Blue Foundry Bancorp
BLFY
-2,770,978
Closed -$33.2M

Similar funds

T. Rowe Price Associates's Q3 2022 Portfolio in Review

As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.

  • T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
  • T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
  • T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
  • T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
  • T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
  • T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
  • T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.

Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.